🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a prospective, non-interventional, post marketing surveillance stud...
Status
Completed
Location
Research Site
Start Date
2008-02
Trial ID
NCT00622323
Glucagon-like peptide-1 receptor agonists (GLP-1RA) are powerful second-lin...
Status
Unknown
Location
Servizio di Diabetologia UOC Medicina Generale
Start Date
2018-12-19
Trial ID
NCT03959865
Extreme pediatric obesity, the fastest growing category of obesity in youth...
Status
Completed
Location
University of Minnesota
Start Date
2010-10
Trial ID
NCT01237197
This study is a placebo-controlled study in both healthy normal subjects an...
Status
Completed
Location
Multiple Locations
Start Date
2005-10
Trial ID
NCT00259896
Treatments Being Tested
This research is randomized, controlled trial. 36 Chinese subjects with Typ...
Status
Unknown
Location
Peking University First Hospital
Start Date
2011-03
Trial ID
NCT01342042
Treatments Being Tested
Phase 3 study to compare treatment with ITCA 650 to sitagliptin when added ...
Status
Withdrawn
Location
Intarcia Therapeutics, Inc
Start Date
2013-02
Trial ID
NCT01455909
Treatments Being Tested
This Phase I clinical study is to evaluate the safety and tolerance of DA-3...
Status
Completed
Location
Clinical Trial center, Clinical Research institute, Seoul National University Hospital
Start Date
2010-07
Trial ID
NCT01156779
Treatments Being Tested
SGLT2 antagonists and GLP1 agonists are used since a relatively short perio...
Status
Completed
Location
Abt. für Endokrinologie & Stoffwechsel, Univ. Klin f. Innere Medizin III
Start Date
2017-03-08
Trial ID
NCT03007329
Treatments Being Tested
This is an open-label study to investigate the feasibility of administering...
Status
Completed
Location
GSK Investigational Site
Start Date
2013-05-16
Trial ID
NCT01857895
Treatments Being Tested
This is a 28-week, multi-center, randomized, double-blind, placebo-controll...
Status
Terminated
Location
Diabeteszentrum Oldenburg
Start Date
2018-02-19
Trial ID
NCT03419624